Results 111 to 120 of about 2,568,308 (394)
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
Corporate Identity: An Analysis of Evolution Over Time
SymphonyaThe aim of the research is to explore the evolution of the Corporate Identity (CI) construct by identifying what constructs of CI are fundamental in each decade, and develop an updated Corporate Identity Taxonomy based on systematic literature review ...
Spyros Panagiotaras +2 more
doaj +1 more source
Molecular Oncology, EarlyView.Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source
A Primer on Corporate Values [PDF]
, 2010 {Excerpt} Advertising strong, positive corporate values is à la mode. Why? In a globalizing world, meaningful values can, for example, instill a sense of identity and purpose in organizations; add spirit to the workplace; align and unify people; promote ...
Serrat, Olivier
core +1 more source
Logo Design and the Corporate Identity
Procedia - Social and Behavioral Sciences, 2012 AbstractThis paper presents the importance of a logo as a graphic element to support a corporate identity. A logo is a graphic identity vector and it has its place in a communication strategy of a company. It is about the signature of a company. That is why is very important to be able to create a harmony between colours and shapes concerning the ...
Nicoleta Elisabeta Pascu +2 more
openaire +2 more sources
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
Korporatiewe Identiteit as Grondslag van die Strafregtelike Aanspreeklikheid van Regspersone (1): Teoretiese Grondslae [PDF]
Potchefstroom Electronic Law Journal, 2011 CORPORATE IDENTITY AS FOUNDATION OF THE CRIMINAL LIABILITY OFLEGAL PERSONS (1): THEORETICAL PRINCIPLESThe different models for the criminal liability of juristic persons reveal a tension between individualist and realistic approaches.
GJ Pienaar, P Du Toit
doaj
Corporate identity: the concept, its measurement and management [PDF]
, 1997 Cees B.M. Van Riel, John M.T. Balmer
openalex +1 more source
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
Molecular Oncology, EarlyView.GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski +19 more
wiley +1 more source
Branding as a development strategy tool [PDF]
Економічний вісник Державного вищого навчального закладу Український державний хіміко-технологічний університетThe key aspects of brand development and management in the contemporary business environment have been analyzed with the aim of achieving competitive advantage and success in the market. The influence of branding on the competitiveness of enterprises has
O. S. Sverdlikovska +3 more
doaj +1 more source